← Leaderboards
Steven S Fakharzadeh
University Of Pennsylvania
$1,426,500
Attributed
$1,426,500
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,426,500 · 2
By mechanism
R01$1,268,000 · 1
R21$158,500 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Mortimer Poncz$48,626,684
- George Cotsarelis$9,881,926
- Joel S. Bennett$17,907,964
- Mohamed H Sayegh$38,781,302
- Stephen G Emerson$28,932,839
Others in their field
Top investigators on “Antibody Formation”
- Dennis R. Burton · Scripps Research Institute$79,778,440
- Susan Abushakra · Alzheon, Inc.$47,690,244
- Kent J. Weinhold · Duke University$41,978,341
- Rama Rao Amara · Emory University$34,508,664
- Rafi Ahmed · Emory University$28,122,278
- Barton F Haynes · Duke University$27,983,877
Research focus
Antibody FormationGenetically Modified AnimalsGenetic TransductionHelper T LymphocyteHemophilia AsHuman TissueKeratinocyteLaboratory MouseRetroviridaeSkinSkin TransplantationTissue /Cell CultureTransfection /Expression VectorVon Willebrand FactorCellular ImmunityCoagulation Factor ViiiCytotoxic T LymphocyteDisease /Disorder ModelGene ExpressionGene TargetingGene TherapyNeoplasm /Cancer DiagnosisNeoplasm /Cancer GeneticsDiagnosis Design /Evaluation
Grant awards (6)
Detection of Novel Gene Defects in Basal Cell Carcinoma$79,250
R21 · FY2005 · AR
EPIDERMIS-TARGETED GENE THERAPY FOR HEMOPHILIA A$317,000
R01 · FY2004 · HL
Detection of Novel Gene Defects in Basal Cell Carcinoma$79,250
R21 · FY2004 · AR
EPIDERMIS-TARGETED GENE THERAPY FOR HEMOPHILIA A$317,000
R01 · FY2003 · HL
EPIDERMIS-TARGETED GENE THERAPY FOR HEMOPHILIA A$317,000
R01 · FY2002 · HL
EPIDERMIS-TARGETED GENE THERAPY FOR HEMOPHILIA A$317,000
R01 · FY2001 · HL